Acta Scientific Ophthalmology (ISSN: 2582-3191)

Research Article Volume 7 Issue 5

Two Year Outcomes of Mitomycin C Augmented Primary Trabeculectomy Surgery Among Patients with Primary Open Angle Glaucoma: A Retrospective STU

Husam Osman Balla Abdalla*, Isiaka Sanni Oluwasegun, Sherifdeen Adebiyi Babatunji and Fatiu Okeowo Lekan

Department of Ophthalmology and Department of Optometry, Makkah Specialist Eye Hospital Kano, Albasar International Foundation, Sudan

*Corresponding Author: Husam Osman Balla Abdalla, Department of Ophthalmology and Department of Optometry, Makkah Specialist Eye Hospital Kano, Albasar International Foundation, Sudan.

Received: March 27, 2024; Published: April 17, 2024


Background: Mitomycin C (MMC) augmented primary trabeculectomy surgery is a very viable option for controlling primary open angle glaucoma (POAG) in a low income country like Nigeria in West Africa. There is limited information about the outcome of trabeculectomy surgery in northwestern Nigeria, West Africa.

Aim: To determine the outcomes of trabeculectomy surgery regarding reduction of post-operative Intra Ocular Pressure (IOP), as well as preserved functional vision among glaucoma patients attending Makkah Specialist Eye Hospital Kano (MSEHK) Nigeria, West Africa.

Materials and Methods: A retrospective glaucoma case notes search for data concerning history of MMC augmented trabeculectomy with a minimum of 6 months post-operative follow-up visit between January 2021 and December 2022 was done. The criteria for a good outcome were post-operative IOP of ≤ 18 but ≥5 mmHg. Consultant ophthalmologists that are contract staff of MSEHK and with expertise in trabeculectomy performed the surgeries.

Results: A total of sixty patients aged 43.32 years (± 12.83), at presentation had a mean aided Snellen’s visual acuity (VA) of 6/10.5 partial; 0.56 (± 0.36) but reduced to 6/12 partial; 0.46 (± 0.31) post-operatively, p = 0.00, mean cup disc ratio was 0.82 (± 0.12) but slightly changed to 0.82 (± 0.12) p = 0.16, and mean spherical equivalence was -0.31D (± 1.45) but also slightly changed to -0.30D (± 1.20) at six months post-surgery. Complete success, qualified success with postoperative use of Misopt and Xolamol were 56 (93.33%), 3 (5.50%), and 1 (1.67%), respectively, no failure observed.

Conclusion: MMC augmented primary trabeculectomy surgery was an effective means as to IOP reduction for POAG patients attending MSEHK, Nigeria with significant topnotch success rates, preserve functional vision but loss of one line of Snellen’s VA. MMC augmented primary trabeculectomy is a very viable treatment option for POAG especially in the low income countries like Nigeria in West Africa.

Keywords: Mitomycin C Augmented Primary Trabeculectomy Surgery; Intra Ocular Pressure; Primary Open Angle Glaucoma; Makkah Specialist Eye Hospital Kano


  1. Ozel AB., et al. “Genome-wide association study and meta-analysis of intraocular pressure”. Human Genetics 133 (2014): 41-57.
  2. Kyari F., et al. “Epidemiology of glaucoma in sub-saharan Africa: prevalence, incidence and risk factors”. Middle East African Journal of Ophthalmology2 (2013): 111.
  3. Konstas AG and Ringvold A. “Epidemiology of exfoliation syndrome”. Journal of Glaucoma 27 (2018): S4-11.
  4. Prum BE., et al. “Primary open-angle glaucoma preferred practice pattern® guidelines”. Ophthalmology1 (2016): P41-111.
  5. Demer JL., et al. “Optic nerve traction during adduction in open angle glaucoma with normal versus elevated intraocular pressure”. Current Eye Research2 (2020): 199-210.
  6. Lee JW., et al. “Latest developments in normal-pressure glaucoma: diagnosis, epidemiology, genetics, etiology, causes and mechanisms to management”. Asia-pacific Journal of Ophthalmology (Philadelphia, Pa.)6 (2019): 457.
  7. Nguyen TD and Ethier CR. “Biomechanical assessment in models of glaucomatous optic neuropathy”. Experimental Eye Research 141 (2015): 125-138.
  8. Sharif NA. “Therapeutic drugs and devices for tackling ocular hypertension and glaucoma, and need for neuroprotection and cytoprotective therapies”. Frontiers in Pharmacology 12 (2021): 729249.
  9. MacIver S., et al. “Screening, diagnosis, and management of open angle glaucoma: an evidence-based guideline for Canadian optometrists”. Canadian Journal of Optometry1 (2017): 5-71.
  10. Megevand GS and Bron AM. “Personalising surgical treatments for glaucoma patients”. Progress in Retinal and Eye Research 81 (2021): 100879.
  11. Bovee CE and Pasquale LR. “Evolving surgical interventions in the treatment of glaucoma”. In Seminars in ophthalmology 32.1 (2017): 91-95.
  12. Turkoski BB. “Glaucoma and glaucoma medications”. Orthopaedic Nursing1 (2012): 37-41.
  13. Mincione F., et al. “Advances in the discovery of novel agents for the treatment of glaucoma”. Expert Opinion on Drug Discovery10 (2021): 1209-1225.
  14. Quigley HA. “21st century glaucoma care”. Eye 2 (2019): 254-260.
  15. Bagnis A., et al. “Current and emerging medical therapies in the treatment of glaucoma”. Expert Opinion on Emerging Drugs2 (2011): 293-307.
  16. Ting NS., et al. “Different strategies and cost-effectiveness in the treatment of primary open angle glaucoma”. Clinico Economics and Outcomes Research (2014): 523-530.
  17. Yadav KS., et al. “Glaucoma: current treatment and impact of advanced drug delivery systems”. Life Sciences 221 (2019): 362-376.
  18. Evangelho K., et al. “Experimental models of glaucoma: A powerful translational tool for the future development of new therapies for glaucoma in humans—A review of the literature”. Medicina 6 (2019): 280.
  19. El Hoffy NM., et al. “Glaucoma: management and future perspectives for nanotechnology-based treatment modalities”. European Journal of Pharmaceutical Sciences 158 (2021): 105648.
  20. Kalouda P., et al. “Achievements and limits of current medical therapy of glaucoma”. Glaucoma Surgery 59 (2017): 1-4.
  21. Ajibode HA., et al. “Assessment of barriers to surgical ophthalmic care in South-Western Nigeria”. Journal of the West African College of Surgeons4 (2012): 68.
  22. Eze BI and Maduka-Okafor FC. “An assessment of the eye care workforce in Enugu State, south-eastern Nigeria”. Human Resources for Health1 (2009): 1-6.
  23. Abdull MM., et al. “Primary open angle glaucoma in northern Nigeria: stage at presentation and acceptance of treatment”. BMC Ophthalmology 15 (2015): 1-8.
  24. Omoti AE., et al. “Surgical management of primary open-angle glaucoma in Africans”. Expert Review of Ophthalmology1 (2015): 95-107.
  25. Awoyesuku EA and Fiebai B. “Outcome of Trabeculectomy in Advanced Glaucoma in a tertiary hospital in Rivers State, Nigeria”. International Journal of Clinical and Experimental Ophthalmology2 (2018): 027-31.
  26. Bettin P., et al. “Glaucoma surgery”. Karger Medical and Scientific Publishers (2017).
  27. Sampaolesi R., et al. “Glaucoma Surgery”. The Glaucomas: Volume II-Open Angle Glaucoma and Angle Closure Glaucoma (2014): 785-878.
  28. Papadopoulos M., et al. “Childhood glaucoma surgery in the 21st century”. Eye8 (2014): 931-943.
  29. Marchini G., et al. “Pediatric glaucoma: current perspectives”. Pediatric Health, Medicine and Therapeutics 5 (2014): 15-27.
  30. Shah C., et al. “Outcomes and risk factors for failure of trabeculectomy with mitomycin C in children with traumatic glaucoma-A retrospective study”. Indian Journal of Ophthalmology2 (2022): 590.
  31. Rao A and Cruz RD. “Trabeculectomy: Does It Have a Future?”. Cureus8 (2022).
  32. Soatiana JE., et al. “Outcomes of trabeculectomy in Africa”. Open Journal of Ophthalmology3 (2013): 76-86.
  33. Yang K., et al. “Interventions to promote follow-up after trabeculectomy surgery in rural southern China: a randomized clinical trial”. JAMA Ophthalmology10 (2016): 1135-1141.
  34. Kipsang RM. “Outcomes of Trabeculectomy at Kenyatta National Hospital and University of Nairobi: a Retrospective Case Series (Doctoral dissertation, University of Nairobi)” .
  35. Isiaka SO., et al. “The Outcomes of Trabeculectomy Surgery among Patients at Makkah Specialist Eye Hospital Bauchi Nigeria”. ORG. 123.1 (2023): 161-170.
  36. Anand N and Dawda VK. “A comparative study of mitomycin C and 5-Fluorouracil trabeculectomy in west Africa”. Middle East African Journal of Ophthalmology1 (2012): 147.
  37. Lawan A. “Pattern of presentation and outcome of surgical management of primary open angle glaucoma in Kano, Northern Nigeria”. Annals of African Medicine4 (2007).
  38. Gauthier AC and Liu J. “Focus: the aging brain: neurodegeneration and neuroprotection in glaucoma”. The Yale Journal of Biology and Medicine1 (2016): 73.
  39. Willekens K., et al. “Trabeculectomy with moorfields conjunctival closure technique offers safety without astigmatism induction”. Journal of Glaucoma5 (2016): e531-535.
  40. Delbeke H., et al. “The effect of trabeculectomy on astigmatism”. Journal of Glaucoma4 (2016): e308-312.


Citation: Husam Osman Balla Abdalla., et al. “Two Year Outcomes of Mitomycin C Augmented Primary Trabeculectomy Surgery Among Patients with Primary Open Angle Glaucoma: A Retrospective STU".Acta Scientific Ophthalmology 7.5 (2024): 35-42.


Copyright: © 2024 Husam Osman Balla Abdalla., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate35%
Acceptance to publication20-30 days
ISI- IF1.042
JCR- IF0.24

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US